Insider trades

Gorman Kevin Charles

Gorman Kevin Charles made 0 buys and 2 sales on the open market in the last 12 months at Neurocrine Biosciences, Inc. and Xencor, Inc. Each trade with the role, price and filing.

DateCompanyTradeSharesPrice
Jun 15, 2026Xencor, Inc.Sale7,527US$12
May 19, 2026Neurocrine Biosciences, Inc.Sale245,088US$154